Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.40 |
| ▸ | FDPS | P14324 | 3/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | LCK | P06239 | 1/20 | 0.39 |
| ▸ | PPARD | Q03181 | 1/20 | 0.39 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.39 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | ADH1B | P00325 | 1/20 | 0.38 |
| ▸ | ADH1C | P00326 | 1/20 | 0.38 |
| ▸ | ADH1A | P07327 | 1/20 | 0.38 |
| ▸ | ADH4 | P08319 | 1/20 | 0.38 |
| ▸ | ADH7 | P40394 | 1/20 | 0.38 |
| ▸ | LAP3 | P28838 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11575563 | 1.00 | MAPT (0.43) | MAPTGPR84FDPSFFAR1LMNA | |
| SCHEMBL1758111 | 0.98 | — | — | |
| SCHEMBL7230764 | 0.90 | — | — | |
| SCHEMBL10638108 | 0.90 | — | — | |
| SCHEMBL7223036 | 0.79 | — | — | |
| SCHEMBL11847336 | 0.76 | TSHR (0.40) | MAPTGPR84FDPSFFAR1LMNA | |
| SCHEMBL11858097 | 0.76 | TSHR (0.40) | MAPTGPR84FDPSFFAR1LMNA | |
| SCHEMBL9395704 | 0.75 | MAPT (0.46) | MAPTGPR84FDPSFFAR1LMNA | |
| SCHEMBL9714347 | 0.75 | MAPT (0.46) | MAPTGPR84FDPSFFAR1LMNA | |
| SCHEMBL10477215 | 0.75 | MAPT (0.46) | MAPTGPR84FDPSFFAR1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12023394-B2 | Vesicle-coated fibers made from crosslinked lipids | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-07-02 | — | — | US | disclosed |
| US-20210346251-A1 | VESICLE-COATED FIBERS MADE FROM CROSSLINKED LIPIDS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2021-11-11 | — | — | US | disclosed |
| US-20110311505-A1 | Photosensitive Aminoacid-Monomer Linkage and Bioconjugation Applications in Life Sciences and Biotechnology | Say, Ridvan (TR) | 2011-12-22 | — | — | US | disclosed |
| WO-2011070402-A1 | PHOTOSENSITIVE AMINOACID-MONOMER LINKAGE AND BIOCONJUGATION APPLICATIONS IN LIFE SCIENCES AND BIOTECHNOLOGY | SAY RIDVAN (TR) | 2011-06-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110311505-A1 | Photosensitive Aminoacid-Monomer Linkage and Bioconjugation Applications in Life Sciences and Biotechnology | BCAT1, BCAT2, AADAT | MAPT 49/4885GPR84 2756/4885FDPS 3691/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.